logo

For the Inventor, By the Inventor

Miami, FL, United States of America

Tissuetech, Inc.


USPTO Granted Patents = 42

% Expired Patents = 11.9



Trademarks = 9

Forward Citations = 813

Loading Chart...
Loading Chart...

16 inventors (with patents filed for the assignee):

goldMedal Scheffer Tseng (37 out of 43 patents)

silverMedal Hua He (27 out of 28 patents)

bronzeMedal Wei Li (10 out of 162 patents)

4.  Wei Li (9 out of 56 patents)

5.  Ek Kia Tan (8 out of 12 patents)

6.  Suzhen Zhang (5 out of 5 patents)

7.  Ying-Ying Gao (5 out of 5 patents)

8.  Scheffer C G Tseng (5 out of 7 patents)

9.  Lorraine Chua (4 out of 6 patents)

10.  Sean Tighe (4 out of 4 patents)

11.  Ying-Tieng Zhu (4 out of 4 patents)

12.  Yingting Zhu (1 out of 1 patent)

13.  Szu-Yu Chen (1 out of 1 patent)

14.  Susanne Binder (1 out of 1 patent)

15.  Helga Sandoval (1 out of 1 patent)


Core Competencies:
Amniotic Membrane
Fetal Support Tissues
Scar Reversal
Epithelial Cells
Bone Remodeling
RNAi Methods
Cell Proliferation
Anti-Inflammation
Anti-Angiogenesis
Tissue Processing
Stem Cell Culturing
Transplantation

42 patents:

1. 11518782 - Compositions containing HC-HA/PTX3 complexes and methods of use thereof (2022-12-06),
2. 11318169 - Compositions and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells (2022-05-03),
3. 11116800 - Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof (2021-09-14),
4. 10717763 - Compositions containing HC-HA/PTX3 complexes and methods of use thereof (2020-07-21),
5. 10632155 - Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition (2020-04-28),
6. 10426731 - Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof (2019-10-01),
7. 10342831 - Composition and methods for preventing the proliferation and epithelial-mesenchymal transition of epithelial cells (2019-07-09),
8. 10272119 - Amniotic membrane preparations and purified compositions and therapy for scar reversal and inhibition (2019-04-30),
9. 10253065 - Compositions containing HC-HA/PTX3 complexes and methods of use thereof (2019-04-09),
10. 10040821 - Compositions containing HC-HA/PTX3 complexes and methods of use thereof (2018-08-07),
11. 9956252 - Purified amniotic membrane compositions and methods of use (2018-05-01),
12. 9931423 - Methods of sterilizing fetal support tissues (2018-04-03),
13. 9808491 - Compositions of morselized umbilical cord and/or amniotic membrane and methods of use thereof (2017-11-07),
14. 9750772 - Amniotic membrane preparations and purified compositions and anti-angiogenesis treatment (2017-09-05),
15. 9750771 - Amniotic membrane preparations and purified compositions and anti-inflammation methods (2017-09-05),
Tissuetech, Inc., based in Miami, FL, specializes in innovative solutions utilizing amniotic membrane and fetal support tissues. The company focuses on advanced therapeutic techniques, including epithelial-mesenchymal transition and scar reversal therapy, aimed at enhancing tissue regeneration and repair. With a strong emphasis on stem cell culturing and RNA interference methods, Tissuetech is dedicated to developing anti-inflammatory strategies and promoting bone remodeling, positioning itself at the forefront of regenerative medicine.
Profile summary based on public USPTO records.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

Tissuetech, Inc.
42 Patents

#16 in Miami, FL

#189 in Florida

#8,253 in US

#16,338 in the World

Miami, FL (US)
Miami, FL, United States of America

Tissuetech, Inc.

Forward Citations = 813

16 inventors:

goldMedal Scheffer Tseng (37 out of 43 patents)

silverMedal Hua He (27 out of 28 patents)

bronzeMedal Wei Li (10 out of 162 patents)

4.  Wei Li (9 out of 56 patents)

5.  Ek Kia Tan (8 out of 12 patents)

Please report any incorrect information to [email protected]
Loading…